iVexSol Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 18

Employees

  • Latest Deal Type
  • Out of Business

iVexSol General Information

Description

Developer of lentiviral vector technology designed to supply a consistent source of vectors for successful gene therapy programs. The company's technology is used for the production of delivery vehicles that are a critical component in the manufacturing of life-changing cell and gene therapies, enabling physicians to treat later-stage cancers and a variety of rare and inherited genetic disorders in both children and adults.

Contact Information

Website
www.ivexsol.com
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 20 Maguire Road
  • Lexington, MA 02421
  • United States
+1 (617)
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 20 Maguire Road
  • Lexington, MA 02421
  • United States
+1 (617)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

iVexSol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 22-Apr-2026 Completed Out of Business
3. Later Stage VC (Series A3) 26-Jan-2023 Completed Generating Revenue
2. Early Stage VC (Series A) 01-Dec-2020 $13.1M $15.4M Completed Generating Revenue
1. Seed Round 05-May-2020 $2.25M $2.25M Completed Startup
To view iVexSol’s complete valuation and funding history, request access »

iVexSol Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Series A2
Series A1
To view iVexSol’s complete cap table history, request access »

iVexSol Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of lentiviral vector technology designed to supply a consistent source of vectors for successful gene therapy
Discovery Tools (Healthcare)
Lexington, MA
18 As of 2024

Rockville, MD
 

Somerville, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

iVexSol Competitors (16)

One of iVexSol’s 16 competitors is Regenxbio, a Formerly VC-backed company based in Rockville, MD.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Regenxbio Formerly VC-backed Rockville, MD
Genetix Biotherapeutics Private Equity-Backed Somerville, MA
Minoryx Venture Capital-Backed Barcelona, Spain
Twist Bioscience Formerly VC-backed South San Francisco, CA
CRISPR Therapeutics Formerly VC-backed Zug, Switzerland
You’re viewing 5 of 16 competitors. Get the full list »

iVexSol Patents

  • 12

    Total Documents Applications and Grants

  • Total Patents Families

  • Granted

  • 7

    Pending

  • Expiring in next 12 mo

iVexSol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
CA-3212812-A1 Compositions and methods for producing and characterizing viral vector producer cells for cell and gene therapy Pending 09-Mar-2021
EP-4304618-A1 Compositions and methods for producing and characterizing viral vector producer cells for cell and gene therapy Pending 09-Mar-2021
US-20240167055-A1 Compositions and methods for producing and characterizing viral vector producer cells for cell and gene therapy Pending 09-Mar-2021
WO-2022192261-A1 Compositions and methods for producing and characterizing viral vector producer cells for cell and gene therapy Inactive 09-Mar-2021
CA-3212829-A1 Compositions and methods for producing and optimizing viral vector producer cells for cell and gene therapy Pending 09-Mar-2021 C12N15/63
To view iVexSol’s complete patent history, request access »

iVexSol Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

iVexSol FAQs

  • When was iVexSol founded?

    iVexSol was founded in 2018.

  • Where is iVexSol headquartered?

    iVexSol is headquartered in Lexington, MA.

  • What is the size of iVexSol?

    iVexSol has 18 total employees.

  • What industry is iVexSol in?

    iVexSol’s primary industry is Discovery Tools (Healthcare).

  • Is iVexSol a private or public company?

    iVexSol is a Private company.

  • What is iVexSol’s current revenue?

    The current revenue for iVexSol is .

  • How much funding has iVexSol raised over time?

    iVexSol has raised $39.2M.

  • Who are iVexSol’s competitors?

    Regenxbio, Genetix Biotherapeutics, Minoryx, Twist Bioscience, and CRISPR Therapeutics are some of the 16 competitors of iVexSol.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process